malignant melanoma; unresectable melanoma; cobimetinib; dabrafenib; ipilimumab; nivolumab; pembrolzumab; trametinib; vemurafenib
Authors' objectives:
To assess the effectiveness and cost-effectiveness of seven new drugs used for inoperable or metastatic malignant melanoma patients relative to each other in the Norwegian setting.
malignant melanoma; unresectable melanoma; cobimetinib; dabrafenib; ipilimumab; nivolumab; pembrolzumab; trametinib; vemurafenib
药械使用 ; 化学药
混合人群
Not Available
